SCHEMBL28967744

SCHEMBL28967744

O=C1c2ccccc2C(=O)N1CCS(=O)(=O)NC(F)C(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 5/20 0.44
GLS O94925 1/20 0.42
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA9 Q16790 1/20 0.40
POLB P06746 2/20 0.40
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP14 P50281 1/20 0.39
ADAM17 P78536 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Taltrimide SCHEMBL29866257 0.82 NPSR1 (0.48) CASP3GLSCA1CA2CA4
Taltrimide SCHEMBL347001 0.82 NPSR1 (0.48) CASP3GLSCA1CA2CA4
SCHEMBL3757316 0.76 GLS (0.49) CASP3GLSCA1CA2CA4
Taltrimide SCHEMBL4621819 0.76 NPSR1 (0.43) CASP3GLSCA1CA2CA4
SCHEMBL3759156 0.75 CASP3 (0.49) CASP3GLSCA1CA2CA4
SCHEMBL29015041 0.74 GLS (0.53) CASP3GLSCA1CA2CA4
SCHEMBL16057269 0.73 GLS (0.42) CASP3GLSCA1CA2CA4
SCHEMBL6029821 0.73 GLS (0.45) CASP3GLSCA1CA2CA4
SCHEMBL20111946 0.73 CASP3 (0.47) CASP3GLSCA1CA2CA4
SCHEMBL11014716 0.72 KDM4E (0.49) GLSCA9POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109369635-B Compound or pharmaceutically acceptable salt thereof, application thereof and pharmaceutical composition 赛克里翁治疗有限公司 2023-06-30 CN disclosed
CN-109384778-B Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder 赛克里翁治疗有限公司 2022-12-13 CN disclosed